Vital Pharmaceuticals, Inc.

United States Bankruptcy Court, S.D. Florida.·Decided October 6, 2023·No. 22-17842·Unknown

Opinion

Sr Ma, ey * AO OS aR’ if * □ iD 8 Ss eA □□□ a Ways A eal’ g □□ \ Ai Ss / Sa pisruct OF oe

ORDERED in the Southern District of Florida on October 6, 2023.

Peter D. Russin, Judge United States Bankruptcy Court

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA FORT LAUDERDALE DIVISION www.flsb.uscourts.gov In re: Case No. 22-17842-PDR Vital Pharmaceuticals, et al., Chapter 11 Debtors. (Jointly Administered) ee MEMORANDUM OPINION AND ORDER DENYING JOHN H. OWOC’S EMERGENCY MOTION FOR CONFIRMATION THE AUTOMATIC STAY DOES NOT APPLY TO REVOCATION OF DEBTOR’S SUBCHAPTER S CORPORATE STATUS OR, ALTERNATIVELY, FOR STAY RELIEF Vital Pharmaceuticals, the Debtor, has recently sold its assets for $370 million. Because Vital is an S corporation, any tax liability from the sale flows to its sole shareholder, John H. Owoc. To avoid the tax liability, Mr. Owoc seeks a determination that the Debtor’s S election is not property of the estate and therefore the automatic stay does not apply to acts he may take that will result in its termination, which will shift the tax liability from him to Vital. Alternatively, Mr.

Owoc seeks stay relief to do so. For the reasons that follow, the Court concludes Vital’s S election is property of the estate and is therefore protected by the automatic stay; Mr. Owoc has failed to demonstrate “cause” to lift the stay; and even if Mr. Owoc had

demonstrated “cause,” it would be futile to lift the stay because Mr. Owoc does not have the right to revoke Vital’s S election. Accordingly, the Court denies Mr. Owoc’s Motion. I. Background. Before S corporations were created in 1958, would-be business owners only had two choices.1 They could incorporate as a C corporation and be shielded from individual liability for the corporation’s debts, but they would be subject to taxation

at the corporate level and again on distributions to the owners at the individual level (otherwise known as double taxation).2 Or they could create a partnership to avoid double taxation, but they would be individually liable for the partnership’s debts.3 Facing criticism that he favored “big business” over the “little guy,” President Dwight D. Eisenhower embraced a proposal by the Treasury Department that eventually led to the creation of the S corporation in 1958, adding a third option that

allowed owners to enjoy limited liability while also avoiding double taxation.4 The S corporation, which was originally limited to small business with fewer than 10

1 The History and Challenges of America’s Dominant Business Structure, S-Corp, https://s-corp.org/our- history/. 2 Id. 3 Id. 4 Id. shareholders, passed corporate income, losses, deductions, and credits to the shareholders, who would then report the income and losses on their personal tax returns and pay taxes on any taxable income at their individual income tax rates.5

John H. “Jack” Owoc founded Vital Pharmaceuticals in 1993.6 As its sole officer and director, Mr. Owoc elected, and as its sole shareholder, Mr. Owoc consented, at the company’s inception that it be treated as an S corporation. As a result, Vital has avoided tax liability by passing its income, losses, deductions, and credits to Mr. Owoc. Mr. Owoc, has been able to avoid double taxation on all distributions from Vital for the past three decades, just as contemplated by the creators of the S corporation.7 In September 2022, significant judgments were entered against Vital. As a

result, Vital appointed John DiDonato as the company’s Chief Transformation Officer (CTO)8 and the following month, filed for chapter 11 bankruptcy.9 Not long after filing, Vital reconstituted its board of directors to add a majority of independent directors.10 On March 9, 2023, Vital’s board removed Mr. Owoc as an officer and director. Vital is currently governed by Mr. DiDonato, who serves as CTO and acting CEO, and a five-member board of directors.

5 Id. Over the years, the cap on the number of shareholders has increased to 100, I.R.C. § 1361(b)(1), which is still a “small business” by today’s standards. 6 Joint Ex. 4, Doc. 1722-4, ¶ 2. 7 Id. 8 Joint Ex. 2, Doc. 1722-2, ¶ 2. 9 Doc. 1. 10 Doc. 637, ¶ 62(b). In January 2023, Vital sought approval to conduct a competitive sale and auction process.11 Vital eventually contracted to sell its assets to Blast Asset Acquisition LLC, a subsidiary of Monster Beverage Corporation.12

The sale price was $370 million, $362 million of which was cash.13 The sale, however, after paying secured debt, was expected to only generate $11.6 million in proceeds for unsecured creditors and nothing for its shareholder, Mr. Owoc.14 But, because Vital is an S corporation, all the taxable income from the sale would flow through to Mr. Owoc, making him liable for the resulting taxes. On July 11, 2023, three weeks before the asset sale was scheduled to close, Mr. Owoc filed his Motion asking the Court to confirm that Vital’s S election is not

property of the estate and that the automatic stay does not bar him from revoking it.15 Alternatively, if the Court concluded Vital’s S election is property of the estate and that the automatic stay does apply, Mr. Owoc asked that the Court grant him relief from the stay so he can revoke it.16 Vital and the Official Committee of Unsecured Creditors objected to Mr. Owoc’s Motion.17 Aside from asserting that the S election is property of the estate and

11 Joint Ex. 7, Doc. 1723-1. 12 Joint Ex. 31, Doc. 1737-2. 13 Joint Ex. 28, Doc. 1733-8. 14 Id. 15 Joint Ex. 4, Doc. 1722-4, ¶¶ 15 – 25. 16 Id. ¶¶ 26 – 29. 17 Joint Ex. 3, Doc. 1722-3; Doc. 1718. therefore protected by the automatic stay, 18 they contended the doctrine of laches bars the relief Mr. Owoc seeks because he waited too long to file his Motion.19 Vital and the Committee also argued there is no cause to lift the stay because if the stay is

lifted and Vital’s S election is revoked, the tax liability Vital would incur would eliminate the $11.6 million distribution to unsecured creditors and render the estate administratively insolvent.20 The Court conducted an evidentiary hearing on Friday, July 28, 2023. The parties’ respective experts testified regarding the potential tax implications of the sale. The experts agreed that if Vital’s S election is revoked, the tax year will be divided into two years—an “S Short Year” (the portion of the year before the S election

is revoked) and a “C Short Year” (the period of the year after the S election is revoked)—and the income and expenses will then be allocated between the S Short Year and C Short Year in one of two ways. The default under Internal Revenue Code § 1362(e)(2), referred to as the “pro rata allocation” approach, is to allocate income and expenses pro rata between the “S Short Year” and “C Short Year” based on how many months out of the year the

company was an S corporation and how many months it was a C corporation.21 For example, if Vital’s S election was revoked on August 1, then 7/12th of its income and

18 Joint Ex. 3, Doc. 1722-3, ¶¶ 43 – 51; Doc. 1718, ¶¶ 6 – 8. 19 Joint Ex. 3, Doc. 1722-3, ¶¶ 21 – 28; Doc. 1718, ¶ 1. 20 Joint Ex. 3, Doc. 1722-3, ¶¶ 57 – 67; Doc. 1718, ¶¶ 9 – 14. 21 Joint Ex. 1, Doc. 1722-1, ¶¶ 18 – 19; I.R.C. § 1362(e)(2). expenses would be allocated to the “S Short Year,” and 5/12th of its income and expenses would be allocated to the “C Short Year.”22 The shareholder then pays the taxes due for the “S Short Year,” while the corporation pays the taxes due for the “C

Free access — add to your briefcase to read the full text and ask questions with AI

Vital Pharmaceuticals, Inc., (Fla. 2023).

Vital Pharmaceuticals, Inc. (Vital Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Parker v. Wendy's International, Inc.
365 F.3d 1268 (Eleventh Circuit, 2004)
Segal v. Rochelle
382 U.S. 375 (Supreme Court, 1966)
Butner v. United States
440 U.S. 48 (Supreme Court, 1979)
United States v. Whiting Pools, Inc.
462 U.S. 198 (Supreme Court, 1983)
Parks v. Dittmar
618 F.3d 1199 (Tenth Circuit, 2010)
In Re Prudential Lines Inc.
928 F.2d 565 (Second Circuit, 1991)
Parker v. Saunders (In Re Bakersfield Westar, Inc.)
226 B.R. 227 (Ninth Circuit, 1998)
Halverson v. Funaro (In Re Frank Funaro, Inc.)
263 B.R. 892 (Eighth Circuit, 2001)
Guinn v. Lines (In Re Trans-Lines West, Inc.)
203 B.R. 653 (E.D. Tennessee, 1996)
In Re Burgess
234 B.R. 793 (D. Nevada, 1999)
Peerless Insurance v. Rivera
208 B.R. 313 (D. Rhode Island, 1997)
Glosband v. Watts Detective Agency, Inc.
21 B.R. 963 (D. Massachusetts, 1981)
T.P. Electric, Inc. v. GGC, LLC (In re GGC, LLC)
329 B.R. 36 (W.D. Pennsylvania, 2005)
In re Denman
513 B.R. 720 (W.D. Tennessee, 2014)